The proteome of human cytomegalovirus virions and dense bodies is conserved across different strains

Medical Microbiology and Immunology

Volumn 204, Issue 3, 2015, Pages 285-293

  Büscher, Nicole ^a   Paulus, Christina ^b   Nevels, Michael ^b   Tenzer, Stefan ^a   Plachter, Bodo ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cytomegalovirus; Dense bodies; HCMV strains; Mass spectrometry; Proteome; UL128 131A; Viral proteins; Virion

Indexed keywords

CAPSID PROTEIN; CYTOMEGALOVIRUS ANTIGEN PP65; GLYCOPROTEIN H; GLYCOPROTEIN L; GLYCOPROTEIN O; GLYCOPROTEIN UL128; GLYCOPROTEIN UL130; GLYCOPROTEIN UL131A; MAJOR CAPSID PROTEIN; PROTEIN IRS1; PROTEIN UL116; PROTEIN UL35; PROTEIN UL43; PROTEIN UL48; PROTEIN UL69; PROTEIN UL70; PROTEIN UL93; PROTEOME; UNCLASSIFIED DRUG; VIRUS PROTEIN; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; PHOSPHOPROTEIN;

ARTICLE; CONTROLLED STUDY; DENSE BODY; HUMAN CYTOMEGALOVIRUS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRAL TROPISM; VIRION; VIRUS STRAIN; CELL CULTURE; CELL LINE; CLASSIFICATION; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; OPEN READING FRAME; PHYSIOLOGY; PROCEDURES; PROTEOMICS; VIROLOGY; VIRUS ASSEMBLY;

CELL LINE; CELLS, CULTURED; CYTOMEGALOVIRUS; ENDOTHELIAL CELLS; HUMANS; MASS SPECTROMETRY; OPEN READING FRAMES; PHOSPHOPROTEINS; PROTEOME; PROTEOMICS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRAL TROPISM; VIRION; VIRUS ASSEMBLY;

EID: 84929961877     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-015-0397-y     Document Type: Article

References (46)

1. Viswanathan K, Früh K (2007) Viral proteomics: global evaluation of viruses and their interaction with the host. Expert Rev Proteomics 4:815–829
2. Maxwell KL, Frappier L (2007) Viral proteomics. Microbiol Mol Biol Rev 71:398–411
3. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DG, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA (2004) Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78:10960–10966
4. Caposio P, Streblow DN, Nelson JA (2013) Cytomegalovirus proteomics. In: Reddehase MJ (ed) Cytomegaloviruses From Molecular Pathogenesis to Intervention. Caister Academic Press, Norfolk, UK, pp 86–108
5. Reyda S, Tenzer S, Navarro P, Gebauer W, Saur M, Krauter S, Büscher N, Plachter B (2014) The tegument protein pp65 of human cytomegalovirus acts as an optional scaffold protein that optimizes protein uploading into viral particles. J Virol 88:9633–9646
6. Reyda S, Büscher N, Tenzer S, Plachter B (2014) Proteomic analyses of human cytomegalovirus strain AD169 derivatives reveal highly conserved patterns of viral and cellular proteins in infected fibroblasts. Viruses 6:172–188
7. Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, Dargan DJ, McGeoch DJ, Gatherer D, Emery VC, Griffiths PD, Sinzger C, McSharry BP, Wilkinson GW, Davison AJ (2004) Genetic content of wild-type human cytomegalovirus. J Gen Virol 85:1301–1312
8. Dargan DJ, Douglas E, Cunningham C, Jamieson F, Stanton RJ, Baluchova K, McSharry BP, Tomasec P, Emery VC, Percivalle E, Sarasini A, Gerna G, Wilkinson GW, Davison AJ (2010) Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol 91:1535–1546
9. Cunningham C, Gatherer D, Hilfrich B, Baluchova K, Dargan DJ, Thomson M, Griffiths PD, Wilkinson GW, Schulz TF, Davison AJ (2010) Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol 91:605–615
10. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM, Shenk TE (2003) Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci USA 100:14976–14981
11. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F (2003) Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA 100:14223–14228
12. Murphy E, Shenk T (2008) Human cytomegalovirus genome. Curr Top Microbiol Immunol 325:1–19
13. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR (1996) Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78–83
14. Wang D, Shenk T (2005) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci USA 102:18153–18158
15. Wang D, Shenk T (2005) Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 79:10330–10338
16. Gerna G, Percivalle E, Lilleri D, Lozza L, Fornara C, Hahn G, Baldanti F, Revello MG (2005) Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J Gen Virol 86:275–284
17. Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A, Wagner M, Gallina A, Milanesi G, Koszinowski U, Baldanti F, Gerna G (2004) Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78:10023–10033
18. Webel R, Hakki M, Prichard MN, Rawlinson WD, Marschall M, Chou S (2014) Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility. J Virol 88:4776–4785
19. Herget T, Freitag M, Morbitzer M, Kupfer R, Stamminger T, Marschall M (2004) Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity. Antimicrob Agents Chemother 48:4154–4162
20. Sinzger C, Schmidt K, Knapp J, Kahl M, Beck R, Waldman J, Hebart H, Einsele H, Jahn G (1999) Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol 80(Pt 11):2867–2877
21. Sinzger C, Hahn G, Digel M, Katona R, Sampaio KL, Messerle M, Hengel H, Koszinowski U, Brune W, Adler B (2008) Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89:359–368
22. Zalckvar E, Paulus C, Tillo D, Asbach-Nitzsche A, Lubling Y, Winterling C, Strieder N, Mücke K, Goodrum F, Segal E, Nevels M (2013) Nucleosome maps of the human cytomegalovirus genome reveal a temporal switch in chromatin organization linked to a major IE protein. Proc Natl Acad Sci USA 110:13126–13131
23. Mücke K, Paulus C, Bernhardt K, Gerrer K, Schön K, Fink A, Sauer EM, Asbach-Nitzsche A, Harwardt T, Kieninger B, Kremer W, Kalbitzer HR, Nevels M (2014) Human cytomegalovirus major immediate early 1 protein targets host chromosomes by docking to the acidic pocket on the nucleosome surface. J Virol 88:1228–1248
24. Tischer BK, Smith GA, Osterrieder N (2010) En passant mutagenesis: a two step markerless red recombination system. Methods Mol Biol 634:421–430
25. Tischer BK, von EJ, Kaufer B, Osterrieder N (2006) Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 40:191–197
26. Chevillotte M, Landwehr S, Linta L, Frascaroli G, Luske A, Buser C, Mertens T, von Einem J (2009) Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J Virol 83:2480–2490
27. Krauss S, Kaps J, Czech N, Paulus C, Nevels M (2009) Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2. J Virol 83:12854–12870
28. Distler U, Kuharev J, Navarro P, Levin Y, Schild H, Tenzer S (2014) Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics. Nat Methods 11:167–170
29. Yu X, Shah S, Lee M, Dai W, Lo P, Britt W, Zhu H, Liu F, Zhou ZH (2011) Biochemical and structural characterization of the capsid-bound tegument proteins of human cytomegalovirus. J Struct Biol 174:451–460
30. Klages S, Rüger B, Jahn G (1989) Multiplicity dependent expression of the predominant phosphoprotein pp65 of human cytomegalovirus. Virus Res 12:159–168
31. Pari GS (2008) Nuts and bolts of human cytomegalovirus lytic DNA replication. Curr Top Microbiol Immunol 325:153–166
32. Adler B, Sinzger C (2013) Cytomegalovirus interstrain variance in cell type tropism. In: Reddehase MJ (ed) Cytomegaloviruses. Caister Academic Press, Norfolk, pp 297–329
33. Zhou M, Yu Q, Wechsler A, Ryckman BJ (2013) Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope. J Virol 87:9680–9690
34. Ryckman BJ, Chase MC, Johnson DC (2010) Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol 84:2597–2609
35. Scrivano L, Sinzger C, Nitschko H, Koszinowski UH, Adler B (2011) HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog 7:e1001256
36. Murrell I, Tomasec P, Wilkie GS, Dargan DJ, Davison AJ, Stanton RJ (2013) Impact of sequence variation in the UL128 locus on production of human cytomegalovirus in fibroblast and epithelial cells. J Virol 87:10489–10500
37. Plotkin SA, Plachter B (2013) Cytomegalovirus Vaccine: On the Way to the Future? In: Reddehase MJ (ed) Cytomegaloviruses: From Molecular Pathogenesis to Intervention. Caister Academic Press, Norfolk, U.K., pp 424–449
38. Kabanova A, Perez L, Lilleri D, Marcandalli J, Agatic G, Becattini S, Preite S, Fuschillo D, Percivalle E, Sallusto F, Gerna G, Corti D, Lanzavecchia A (2014) Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies. Proc Natl Acad Sci USA 111:17965–17970
39. Lilleri D, Kabanova A, Revello MG, Percivalle E, Sarasini A, Genini E, Sallusto F, Lanzavecchia A, Corti D, Gerna G (2013) Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection. PLoS ONE 8:e59863
40. Lilleri D, Kabanova A, Lanzavecchia A, Gerna G (2012) Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo. J Clin Immunol 32:1324–1331
41. Macagno A, Bernasconi NL, Vanzetta F, Dander E, Sarasini A, Revello MG, Gerna G, Sallusto F, Lanzavecchia A (2010) Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 84:1005–1013
42. Saccoccio FM, Sauer AL, Cui X, Armstrong AE, Habib ESE, Johnson DC, Ryckman BJ, Klingelhutz AJ, Adler SP, McVoy MA (2011) Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells. Vaccine 29:2705–2711
43. Freed DC, Tang Q, Tang A, Li F, He X, Huang Z, Meng W, Xia L, Finnefrock AC, Durr E, Espeseth AS, Casimiro DR, Zhang N, Shiver JW, Wang D, An Z, Fu TM (2013) Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proc Natl Acad Sci USA 110:E4997–E5005
44. Wussow F, Chiuppesi F, Martinez J, Campo J, Johnson E, Flechsig C, Newell M, Tran E, Ortiz J, La RC, Herrmann A, Longmate J, Chakraborty R, Barry PA, Diamond DJ (2014) Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex. PLoS Pathog 10:e1004524
45. Wen Y, Monroe J, Linton C, Archer J, Beard CW, Barnett SW, Palladino G, Mason PW, Carfi A, Lilja AE (2014) Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice. Vaccine 32:3796–3804
46. Mocarski ES, Shenk T, Griffiths PD, Pass RF (2013) Cytomegaloviruses. In: Knipe DM, Howley PM (eds) Fields virology. Wolters Kluwer Lippincott Williams & Wilkins, Philadelphia, pp 1960–2014